This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Hypertrophic cardiomyopathy (HCM) is commonly associated with atrialfibrillation (AF), but its impact on outcomes in real-world practice is uncertain. Patients with AF had a higher annual incidence of stroke/transient ischaemic attack (2.6 Methods Overall, 1739 adult patients with HCM (40.9% women; median age: 55.5
People with conditions or habits such as high blood pressure, an irregular heartbeat called atrialfibrillation, or smoking, not only have a higher risk of stroke, they may also have more severe strokes than people without these riskfactors.
Atrialfibrillation (AFib) is a common heart rhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heart failure, making it essential to understand its causes, symptoms, and AFib treatment options. What is AtrialFibrillation?
BackgroundNon-valvular atrialfibrillation (NVAF) significantly increases ischemic stroke and systemic embolism (SE) risks. Despite the proven efficacy of oral anticoagulants (OAC) in reducing these risks, their underutilization highlights a gap in clinical practice. for stroke/SE-specific, p-value<0.001).
Background Atrialfibrillation (AF) and acute myocardial infarction (AMI) share riskfactors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.
People with conditions or habits such as high blood pressure, an irregular heartbeat called atrialfibrillation, or smoking, not only have a higher risk of stroke, they may also have more severe strokes than people without these riskfactors, according to a study published in the journal Neurology.
BACKGROUND:Cardiovascular disease and stroke are common and costly, and their prevalence is rising. to 3.8%), stroke (3.9% to 6.4%), atrialfibrillation (1.7% in 2020 to 61.0% Diabetes (16.3% to 26.8%) and obesity (43.1% to 60.6%) will increase, whereas hypercholesterolemia will decline (45.8% to 15.0%) will rise.
Atrialfibrillation is the most prevalent sustained cardiac arrhythmia and an important riskfactor for ischemic stroke resulting in a fivefold increased strokerisk.
BackgroundAtrial fibrillation (AF) is known to be a strong riskfactor for stroke. However, the risk of stroke recurrence in patients with cryptogenic stroke with AF detected after stroke by an insertable cardiac monitor (ICM) is not well known. in 249 patients without AF detection and 5.8%
A projected rise in heart disease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 It is not surprising that an enormous increase in cardiovascular riskfactors and diseases will produce a substantial economic burden."
Atrialfibrillation (AF) is the most common arrhythmia in the U.S., Black Americans are less prone to develop AF than White Americans, but they display a higher burden of modifiable riskfactors for cardiovascular disease and higher rates of ischemic stroke.
The human capital approach was used to estimate productivity losses from morbidity and premature mortality due to cardiovascular conditions.RESULTS:One in 3 US adults received care for a cardiovascular riskfactor or condition in 2020. Stroke is projected to account for the largest absolute increase in costs.
We are diagnosing atrialfibrillation (AF) more often that at any time in history. This is driven by the aging of our populations, the growing prevalence of AF riskfactors and by the proliferation of longer-term electrocardiographic monitoring, including patient-facing technologies 1,2.
Atrialfibrillation (AF) is the most common sustained cardiac rhythm disorder, affecting an estimated 43 million people globally. 1 Long-term AF management, including outpatient visits, hospitalisations and disabilities from stroke and heart failure (HF), adds substantial burden on healthcare resources and costs, accounting for 2.6%
2023 ACC/AHA/ACCP/HRS guidelines suggest that patients with Atrialfibrillation (AF) at intermediate to low annual risk of ischemic stroke can benefit from consideration of factors that might modify their risk of stroke.
Stroke, Volume 55, Issue Suppl_1 , Page ATP254-ATP254, February 1, 2024. Introduction:Clinical characteristics of patients with in-hospital onset stroke (IHOS) compared to those with out-of-hospital onset stroke are reported to be late detection of stroke onset, less use of rt-PA, presence of atrialfibrillation, and poor outcome.
Affecting 60 million people worldwide 1 , the prevalence of atrialfibrillation (AFib) is expected to increase by 60% by 2050 due to an aging population and rising cardiometabolic riskfactors 2. In a physician survey, the foremost barrier to patients taking oral anticoagulants was the risk of bleeding 5.
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrialfibrillation (AFib).
Stroke, Volume 55, Issue Suppl_1 , Page ATMP87-ATMP87, February 1, 2024. Background and purpose:Because the biochemical composition of thrombus changes after formation over time, thrombus maturation in the left atrium may affect clot compositions in ischemic stroke with atrialfibrillation (AF).
Mechanisms and potential targets to manage atrialfibrillation related to diabetes mellitus are represented. ABSTRACT In spite of significant progress made in the management in recent decades, atrialfibrillation (AF) continues to cause increased mortality and significant morbidities, including heart failure and stroke.
Atrialfibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. In some cases, AFib can also increase the risk of stroke, blood clots and heart failure. Maintain a Healthy Weight – Excess weight is a major riskfactor for AFib.
Background Atrialfibrillation (AF), a common, frequently asymptomatic cardiac arrhythmia, is a major riskfactor for stroke. Identification of AF enables effective preventive treatment to be offered, potentially reducing strokerisk by up to two-thirds.
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Global epidemiology of atrialfibrillation: An increasing epidemic and public health challenge. Int J Stroke.
Introduction:Stroke prevention with anticoagulation is an important aspect of atrialfibrillation (AF) management. Anticoagulation is often based on the premise that the risk of stroke increases with each additional CHA2DS2VASc riskfactor. 1.22) for stroke in the full cohort (p< 0.001).
BackgroundAs the population ages, atrialfibrillation (AF) prevalence increases, but data on optimal oral anticoagulation (OAC) in patients 80 years remain limited. Data were analyzed by age for outcomes and riskfactors for predefined end points.ResultsPatients 80 years comprised 32.2% of AF cases. of AF cases.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionOver the past decade, non‐vitamin K antagonist oral anticoagulants (NOACs) have replaced warfarin as the initial strategy for stroke prevention in non‐valvular atrialfibrillation. 94.48]), HbA1c levels (aOR 2.36, 95% CI [1.39–3.99]),
Background Atrialfibrillation (AF) following coronary artery bypass graft surgery (CABG) is common and results in significant increases in hospital stay and financial encumbrance. Objective Determine and use the predictors of postoperative AF (POAF) following CABG to develop a new predictive screening tool.
Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular riskfactors in patients with hemophilia compared to the general population.
Stroke, Volume 55, Issue Suppl_1 , Page A96-A96, February 1, 2024. Introduction:While ischemic stroke (IS) in the young (18-55) is thought to have different etiologies than in older patients, a rise in vascular riskfactors (VRFs) among young adults may translate to an IS risk profile similar to the older population.
The optimal management of AtrialFibrillation (AF) requires management of strokerisk, heart rate and rhythm control, and management of riskfactors. Many AF riskfactors are lifestyle related and require patients to engage in health behaviour change.
ABSTRACT Background Aging of the population has resulted in more patients living with atrialfibrillation (AF) and age-related macular degeneration (AMD). There is also an increase in age-related macular degeneration (AMD), which shares many pathophysiologic riskfactors of AF. vs. 1.1%, p <0.0001), stroke (4.6%
Stroke, Volume 56, Issue Suppl_1 , Page ATP136-ATP136, February 1, 2025. Once these post-stroke patients have been identified, they are given a personalized monitoring plan depending on the individuals riskfactors, the personalized care and rehabilitation plans are tracked and followed.
A notched P wave is also known to predict atrialfibrillation (AF) after catheter ablation. 6.01, p=0.004) and ischemic stroke (HR 3.02, 95% CI 1.56–5.83, 14.71, p = 0.011) and ischemic stroke (HR 3.84, 95% CI 1.20–12.29, 5.83, P=0.001). 12.29, P=0.024).Conclusions:A
Hypertension is the single most important riskfactor for development of atrialfibrillation (AF), which may be considered as a cardiac manifestation of hypertensive target organ damage. Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heart failure and stroke.
Stroke, Volume 56, Issue Suppl_1 , Page AWP279-AWP279, February 1, 2025. Introduction:Neurological complications in patients with infective endocarditis (IE), such as ischemic and hemorrhagic stroke, are well-described, serious complications of IE; however, predicting which patients are most likely to experience stroke remains uncertain.
Stroke is a major cause of mortality, morbidity and economic burden. Strokes can be thrombotic, embolic or haemorrhagic. The key riskfactor for cardioembolic stroke is atrialfibrillation or flutter, and oral anticoagulation (OAC) is recommended in all but the lowest-risk patients with evidence of these arrhythmias.
Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025. Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrialfibrillation (AF) patients. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular riskfactors for ICH.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP105-AWMP105, February 1, 2024. Background:Previous trans-ancestry genome-wide association studies (GWAS) of stroke reported 32 strokerisk loci, which were conducted predominantly in populations of European ancestry.
Stroke: Vascular and Interventional Neurology, Volume 4, Issue 6 , November 1, 2024. BackgroundAtrial fibrillation (AF) is a known riskfactor of ischemic stroke, and AFrelated stroke is twice more likely to be fatal. The average time to inpatient ICM implant was 4.1 days, with 77% in 5 days and 95.5%
Stroke, Volume 55, Issue Suppl_1 , Page ATP252-ATP252, February 1, 2024. The data supporting FHP as a true riskfactor of posterior circulation stroke has not been well established. We then identified matched pair case-controls (based on age and gender) with non-stroke cervical myalgia patients in the same 5-year period.
Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Christian Hengstenberg, Martin Unverdorben, Helge Möllmann, Nicolas M. Van Mieghem, Holger Thiele, Peter Nordbeck, Tienush Rassaf, Raul Moreno, Roxana Mehran, James Jin, Irene Lang, Roland Veltkamp, George D.
Stroke is often due to sudden loss of blood supply to a region of the brain which usually results in paralysis of a part of the body. Stroke could also be due to bleeding into a part of the brain. Strokes and heart disease are linked together in various ways. Stroke can occur after a heart attack as well.
Stroke, Volume 55, Issue Suppl_1 , Page AWP241-AWP241, February 1, 2024. Background:Migraine with aura is a riskfactor for ischemic stroke. We refined the migraine with aura risk score (MARS) to create the migraine associated risk of stroke score (MARS Plus) making it applicable to migraine with and without aura.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
88 
Let's personalize your content